Wenxiang Wang

1.6k total citations · 2 hit papers
31 papers, 994 citations indexed

About

Wenxiang Wang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Wenxiang Wang has authored 31 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 22 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Wenxiang Wang's work include Cancer-related molecular mechanisms research (14 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (6 papers). Wenxiang Wang is often cited by papers focused on Cancer-related molecular mechanisms research (14 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (6 papers). Wenxiang Wang collaborates with scholars based in China, Switzerland and United States. Wenxiang Wang's co-authors include Min Su, Yuhang Xiao, Qianjin Liao, Bo Tian, Zhining Wu, Desong Yang, Li Xu, Ta Xiao, Junliang Ma and Yong Zhou and has published in prestigious journals such as Scientific Reports, Molecular Cancer and Medicine.

In The Last Decade

Wenxiang Wang

31 papers receiving 990 citations

Hit Papers

Circular RNAs in Cancer: emerging functions in hallmarks,... 2019 2026 2021 2023 2019 2024 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenxiang Wang China 14 820 628 120 72 65 31 994
Fabio Corrà Italy 10 634 0.8× 505 0.8× 156 1.3× 52 0.7× 20 0.3× 14 828
Anthony D. Saleh United States 14 573 0.7× 395 0.6× 228 1.9× 67 0.9× 24 0.4× 31 1.0k
Meimei Wan United States 16 659 0.8× 306 0.5× 117 1.0× 68 0.9× 25 0.4× 21 915
Zerong Cai China 10 1.0k 1.2× 750 1.2× 125 1.0× 77 1.1× 15 0.2× 25 1.2k
Rikki A. M. Brown Australia 10 530 0.6× 484 0.8× 83 0.7× 93 1.3× 18 0.3× 11 783
Marcel Köhn Germany 12 1.2k 1.4× 675 1.1× 91 0.8× 40 0.6× 15 0.2× 20 1.3k
Yi Sang China 19 885 1.1× 433 0.7× 220 1.8× 108 1.5× 22 0.3× 44 1.1k
Yifei Feng China 14 508 0.6× 250 0.4× 161 1.3× 80 1.1× 22 0.3× 28 664
Zhu Mei China 13 609 0.7× 331 0.5× 206 1.7× 81 1.1× 20 0.3× 22 850

Countries citing papers authored by Wenxiang Wang

Since Specialization
Citations

This map shows the geographic impact of Wenxiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenxiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenxiang Wang more than expected).

Fields of papers citing papers by Wenxiang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenxiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenxiang Wang. The network helps show where Wenxiang Wang may publish in the future.

Co-authorship network of co-authors of Wenxiang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenxiang Wang. A scholar is included among the top collaborators of Wenxiang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenxiang Wang. Wenxiang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Yong, Yunqing Xuan, Wenxiang Wang, et al.. (2025). Rapid and cost-effective screening of therapeutic targets for isoquercitrin in insulin resistance using virtual methods and fiber SPR biosensing. Biomedical Optics Express. 16(3). 1090–1090. 1 indexed citations
2.
Ma, Yi, Haiming Chen, Haoran Li, et al.. (2024). Intratumor microbiome-derived butyrate promotes lung cancer metastasis. Cell Reports Medicine. 5(4). 101488–101488. 68 indexed citations breakdown →
3.
Chen, Haiming, Yi Ma, Wenxiang Wang, et al.. (2024). Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancer. Cell Reports Medicine. 5(4). 101499–101499. 21 indexed citations
4.
Chen, Kezhong, et al.. (2024). Development of new techniques and clinical applications of liquid biopsy in lung cancer management. Science Bulletin. 69(10). 1556–1568. 11 indexed citations
5.
Wang, Wenxiang, et al.. (2023). Advances in the diagnosis and prognosis of minimal residual lesions of breast cancer. Pathology - Research and Practice. 245. 154428–154428. 7 indexed citations
6.
Ma, Junliang, Shaolin Chen, Min Su, & Wenxiang Wang. (2023). High FN1 expression is associated with poor survival in esophageal squamous cell carcinoma. Medicine. 102(14). e33388–e33388. 6 indexed citations
7.
Wang, Wenxiang, et al.. (2023). Current and emerging applications of liquid biopsy in pan-cancer. Translational Oncology. 34. 101720–101720. 7 indexed citations
8.
Zhang, Yang, Shun‐Qing Liang, Liang Zhao, et al.. (2022). Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer. Journal of Experimental & Clinical Cancer Research. 41(1). 25–25. 13 indexed citations
9.
Su, Min, Jinming Tang, Desong Yang, et al.. (2022). Oncogenic roles of the lncRNA LINC00460 in human cancers. Cancer Cell International. 22(1). 240–240. 5 indexed citations
10.
Wang, Liqiang, et al.. (2021). The Functional Characterization of Epigenetically Related lncRNAs Involved in Dysregulated CeRNA–CeRNA Networks Across Eight Cancer Types. Frontiers in Cell and Developmental Biology. 9. 649755–649755. 18 indexed citations
11.
Xiao, Ta, Yuhang Xiao, Wenxiang Wang, et al.. (2020). Targeting EphA2 in cancer. Journal of Hematology & Oncology. 13(1). 114–114. 147 indexed citations
12.
Xiao, Yuhang, Ta Xiao, Wei Ou, et al.. (2020). LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers. Biomarker Research. 8(1). 41–41. 33 indexed citations
13.
Zhou, Yong, Bo Tian, Jinming Tang, et al.. (2020). SNHG7: A novel vital oncogenic lncRNA in human cancers. Biomedicine & Pharmacotherapy. 124. 109921–109921. 37 indexed citations
14.
Su, Min, Yuhang Xiao, Junliang Ma, et al.. (2019). Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers. Molecular Cancer. 18(1). 90–90. 321 indexed citations breakdown →
15.
Ma, Junliang, Yuhang Xiao, Bo Tian, et al.. (2019). Genome-wide analyses of long non-coding RNA expression profiles and functional network analysis in esophageal squamous cell carcinoma. Scientific Reports. 9(1). 9162–9162. 14 indexed citations
16.
Xiao, Yuhang, Min Su, Wei Ou, et al.. (2019). Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer. Biomedicine & Pharmacotherapy. 117. 109192–109192. 17 indexed citations
17.
Wang, Wenxiang, et al.. (2018). MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2. Biomedicine & Pharmacotherapy. 107. 712–720. 35 indexed citations
18.
Su, Min, Heran Wang, Wenxiang Wang, et al.. (2018). LncRNAs in DNA damage response and repair in cancer cells. Acta Biochimica et Biophysica Sinica. 50(5). 433–439. 50 indexed citations
19.
Su, Min, Yuhang Xiao, Jinming Tang, et al.. (2018). Role of lncRNA and EZH2 Interaction/Regulatory Network in Lung Cancer. Journal of Cancer. 9(22). 4156–4165. 53 indexed citations
20.
Liu, Shenggang, et al.. (2002). Can Millimeter Waves Generate Electroporation?. International Journal of Infrared and Millimeter Waves. 23(8). 1261–1269. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026